English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Rescued from desperation: adult-onset Still’s disease with life-threatening interstitial lung disease and macrophage activation: Successful treatment by Tocilizumab Aus der Verzweiflung gerettet: Morbus Still des Erwachsenen mit lebensbedrohlicher interstitieller Pneumonie und Makrophagenaktivierungssyndrom: Erfolgreiche Therapie durch Tocilizumab Journal article
Zhang, Guangfeng, Liu, Wenxue, Zhang, Xiao, Liu, Liang. Rescued from desperation: adult-onset Still’s disease with life-threatening interstitial lung disease and macrophage activation: Successful treatment by Tocilizumab Aus der Verzweiflung gerettet: Morbus Still des Erwachsenen mit lebensbedrohlicher interstitieller Pneumonie und Makrophagenaktivierungssyndrom: Erfolgreiche Therapie durch Tocilizumab[J]. Zeitschrift fur Rheumatologie, 2022, 81(4), 335-338.
Authors:  Zhang, Guangfeng;  Liu, Wenxue;  Zhang, Xiao;  Liu, Liang
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:0.9/1.0 | Submit date：2023/01/30
Adult-onset Still’s Disease  Interstitial Lung Disease  Macrophage Activation Syndrome  Tocilizumab  Treatment Resistance  
Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo Journal article
Rehan V.K., Wang Y., Patel S., Santos J., Torday J.S.. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo[J]. Pediatric Pulmonology, 2006, 41(6), 558-569.
Authors:  Rehan V.K.;  Wang Y.;  Patel S.;  Santos J.;  Torday J.S.
Favorite | TC[WOS]:66 TC[Scopus]:74 | Submit date：2019/01/16
Alveolar Interstitial Fibroblast  Bronchopulmonary Dysplasia  Chronic Lung Disease  Hyperoxia  Lipofibroblast  Myofibroblast  Peroxisome Proliferator-activated Receptor-γ